Literature DB >> 8483522

Syringomyelia: a brief review of ontogenetic, experimental and clinical aspects.

E Donauer1, K Rascher.   

Abstract

The generally accepted definition of syringomyelia is that it is a chronically progressive illness characterized by the presence of cavities or syrinxes in the spinal cord. As manifold as the terminology of syringomyelia are the hypotheses of the etiology. Nowadays with MRI without and with gadolinium it is possible to recognize intramedullar cavities safely, the MR especially the cine-MR provides information on pathophysiological details of the flow and intracavitary pressure dependent pulsations of the CSF. Animal models and the findings of own experimental studies have enabled us to study a form of syringomyelia which very closely resembles that brought about by dysrhaphic malformations in the human being and to examine the effectiveness of certain types of surgical therapy. In this paper the term syringomyelia is only used for dysrhaphic cavities in the medulla. After our experience with 61 patients with syringomyelia now we perform the operative decompression of the craniocervical transition as the first step in the operative treatment of the progressive syringomyelia combined with severe craniocervical malformations. In cases with insufficient treatment response we suggest the syringoarachnoid shunting of persisting large intramedullar cavities.

Entities:  

Mesh:

Year:  1993        PMID: 8483522     DOI: 10.1007/bf00308604

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  32 in total

1.  SYRINGOMYELIA: CURRENT STATUS OF SURGICAL THERAPY.

Authors:  F W PITTS; R A GROFF
Journal:  Surgery       Date:  1964-10       Impact factor: 3.982

2.  Ascending spinal paralysis; case presentation.

Authors:  L W FREEMAN
Journal:  J Neurosurg       Date:  1959-01       Impact factor: 5.115

3.  The mechanism of syringomyelia and its surgical correction.

Authors:  W J GARDNER; J ANGEL
Journal:  Clin Neurosurg       Date:  1958

4.  Syringomyelia; a clinicopathologic study.

Authors:  M G NETSKY
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-12

5.  Structural alterations in the spinal cord during progressive communicating syringomyelia. An experimental study in the cat.

Authors:  K Rascher; K H Booz; E Donauer; A C Nacimiento
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

6.  Management of syringomyelia: a pathophysiological approach.

Authors:  S J Peerless; Q J Durward
Journal:  Clin Neurosurg       Date:  1983

7.  Syringoperitoneal shunt for treatment of cord cavitation.

Authors:  M Suzuki; C Davis; L Symon; F Gentili
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

8.  Progressive myelopathy as a sequel to traumatic paraplegia.

Authors:  H J Barnett; E H Botterell; A T Jousse; M Wynn-Jones
Journal:  Brain       Date:  1966-03       Impact factor: 13.501

9.  Syringoperitoneal shunt for syringomyelia: a preliminary report.

Authors:  T W Phillips; G W Kindt
Journal:  Surg Neurol       Date:  1981-12

10.  Experimental hydrocephalus and hydrosyringomyelia. Computertomographic studies.

Authors:  E Donauer; W Wussow; K Rascher
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

View more
  1 in total

1.  Charles Prosper Ollivier d'Angers (1796-1845) and his contributions to defining syringomyelia.

Authors:  Martin M Mortazavi; Olivia J Rompala; Ketan Verma; Isaiah Tubbs; R Shane Tubbs; Aaron A Cohen-Gadol
Journal:  Childs Nerv Syst       Date:  2011-03-10       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.